Pacific Biosciences of California PACB Consumable revenue — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's consumable revenue — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's consumable revenue — total revenue?
- Pacific Biosciences of California (PACB) reported consumable revenue — total revenue of $21.81M in Q1 2026.
- How has Pacific Biosciences of California's consumable revenue — total revenue changed year-over-year?
- Pacific Biosciences of California's consumable revenue — total revenue increased by 8.5% year-over-year, from $20.1M to $21.81M.
- What is the long-term trend for Pacific Biosciences of California's consumable revenue — total revenue?
- Over 4 years (2021 to 2025), Pacific Biosciences of California's consumable revenue — total revenue has grown at a 11.9% compound annual growth rate (CAGR), from $52.18M to $81.94M.
- What does consumable revenue — total revenue mean?
- This metric represents the revenue generated from the sale of recurring, platform-specific consumable products required to operate genetic sequencing systems. It serves as a key indicator of the installed base utilization and the long-term recurring revenue potential of the company's core technology platform. Growth in this segment reflects increasing customer adoption and ongoing usage of the company's sequencing solutions.